Vilamakitug

维拉奇塔单抗

Report date: 2026/05/15 20:01:45

Base Information

Drug NameVilamakitug
Drug Alias NameNatrunix-SQNatrunixXB-2001
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionInterleukin-1 alpha inhibitors
TargetsInterleukin-1 alpha
Therapy Area/IndicationsAxial SpondyloarthritisRheumatic DiseasesArthritis, Rheumatoid +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesXbiotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesXbiotech Inc
Inactive CompaniesN/A
Active IndicationsAxial SpondyloarthritisRheumatic DiseasesArthritis, Rheumatoid +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A